Biovie (BIVI) Operating Leases (2022 - 2026)
Biovie's Operating Leases was $184,421 in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 33.0% from $275,430 a year earlier and down 13.5% from the prior quarter.
Powered by 
Analysis
Biovie (BIVI) Operating Leases (2022 - 2026) Analysis & Trends
From fiscal Q3 2022 onward, Biovie has reported Operating Leases for 18 quarters.
- Operating Leases shows a four-year compound annual growth rate of 20.5% (FY2022 to FY2026).
- In earlier fiscal years, Operating Leases was $275,430 in FY2025 (-21.3%), $349,894 in FY2024 (+723.2%), $42,505 in FY2023 (-51.4%) and $87,414 in FY2022.
- The fiscal Q4 2026 figure marks the lowest quarterly Operating Leases since fiscal Q2 2024.
- Compared with a year earlier, Operating Leases has declined for six straight quarters, with an average decline of 25.2% over the last six quarters.
- The best year-over-year quarter for Operating Leases over five years was fiscal Q4 2024 (growth of 723.2%); the worst was fiscal Q2 2024 (a decline of 73.3%).
- Per Business Quant data, BIVI's Operating Leases in the three fiscal quarters before Q4 2026 was $213,319 (Q3 2026), $232,517 (Q2 2026) and $254,373 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Biovie | 11.62 Mn | 11.62 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 184,421.00 |
| Mar 31, 2026 | 213,319.00 |
| Dec 31, 2025 | 232,517.00 |
| Sep 30, 2025 | 254,373.00 |
| Jun 30, 2025 | 275,430.00 |
| Mar 31, 2025 | 295,717.00 |
| Dec 31, 2024 | 314,915.00 |
| Sep 30, 2024 | 332,730.00 |
| Jun 30, 2024 | 349,894.00 |
| Mar 31, 2024 | 366,430.00 |
| Dec 31, 2023 | 17,604.00 |
| Sep 30, 2023 | 30,221.00 |
| Jun 30, 2023 | 42,505.00 |
| Mar 31, 2023 | 54,465.00 |
| Dec 31, 2022 | 65,835.00 |
| Sep 30, 2022 | 76,768.00 |
| Jun 30, 2022 | 87,414.00 |
| Mar 31, 2022 | 97,779.00 |
API Access
Biovie Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=BIVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "BIVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=BIVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();